Co-Chairs

Donna Meuth

Associate General Counsel, Intellectual Property
Eisai Inc. (Cambridge, MA)

Co-Chair’s Opening Remarks

November 14, 2019 8:00 am

Timothy Witkowski

Global Head, Chemistry Patents
Novartis Institutes for BioMedical Research (NIBR) (Cambridge, MA)

Co-Chair’s Opening Remarks

November 14, 2019 8:00 am

Speakers

Beth Arnold

Founder
BioPharma Patent Landscapes

Jens Bitsch-Norhave

Vice President, Transactions
Johnson & Johnson Innovation LLC (Cambridge, MA)

Nick Boivin

Deputy General Counsel, Head of IP
FORMA Therapeutics, Inc.

Heather Boussios

Assistant General Counsel and Head of Intellectual Property, Legal Department
Aptevo Therapeutics (Seattle, WA)
Maureen Bresnahan

Maureen Bresnahan

Assistant General Counsel
Eisai Inc.

Sharon E. Crane

Member
Rothwell, Figg, Ernst & Manbeck, P.C (Washington, DC)

Ryan M. Daniel

Acting Chief Patent Counsel
Fresenius Kabi USA, LLC (Lake Zurich, IL)

Philip I. Datlow

Director & Senior Counsel II, IP
Boehringer Ingelheim USA Corp. (Ridgefield, CT)

Michael A. Davitz

Partner
Leason Ellis (White Plains, NY)

David J. Dykeman

Shareholder
Greenberg Traurig, LLP (Boston, MA)

Philippe Edouard

Senior Director Intellectual Property, Legal
Takeda Pharmaceutical Company Limited (Lexington, MA)

MJ Edwards

Senior Counsel, IP
Gilead Sciences

Sylvia Georges Evangelinos

Senior Patent Attorney
Novartis Institutes for BioMedical Research (NIBR) (Cambridge, MA)

Rebecca Goodman

Senior Corporate Counsel
Celgene (Summit, NJ)

Philip Green

Principal
Hoffman Alvary & Company LLC (Newton, MA)

Jennifer Gregory

Assistant General Patent Counsel, IP Transactions
Eli Lilly and Company (Indianapolis, IN)

Henry H. Gu

Vice President, Chief IP Counsel
Akebia Therapeutics, Inc. (Cambridge, MA)

R. Frederic Henschel

Partner
Potomac Law Group, PLLC

Danielle Herritt

Partner
Womble Bond Dickinson

Andrew K. Holmes

Patent Attorney
Novartis Pharmaceuticals (East Hanover, NJ)

Tom Irving

Partner
Finnegan, Henderson, Farabow, Garret & Dunner, LLP (Washington, DC)

Kurt R. Karst

Director
Hyman, Phelps & McNamara PC (Washington, DC)

Hilary J. Libka

Intellectual Property Counsel
Dana-Farber Cancer Institute, Inc. (Boston, MA)

John Christopher LiPuma

Vice President, Investment Professional
Fortress Investment Group (New York, NY)

Cara Z. Lowen

VP and Chief IP Counsel
Codiak BioSciences (Waltham, MA)

Jane M. Love

Partner
Gibson Dunn (New York, NY)

Mike McGurk

Founding Member
McGurk Group LLP (Boston, MA)

Mercedes K. Meyer

Partner
Drinker, Biddle & Reath LLP (Washington, DC)

Ryan Murphey

Counsel
Ropes & Gray LLP (New York, NY)

Jeffrey N. Myers

Vice President & Assistant General Counsel
Pfizer Inc. (New York, NY)
Asha Nadipuram

Asha Nadipuram

Patent Attorney
Novartis Institutes for BioMedical Research (NIBR)

Angela Ni

Director of Underwriting and Data Strategies
Parabellum Capital LLC (New York, NY)

Michael K. Stern

Of Counsel
Covington & Burling LLP (Washington, DC)

Adam Strauss

Chief Intellectual Property Counsel
Stryker (Kalamazoo, MI)

Sonia Vallabh

Prion Scientist
Broad Institute (Cambridge, MA)

Marina Volin

VP, Head of Legal and IP
Kintai Therapeutics, Inc. (Cambridge, MA)

Jeffrey Wade

Executive Vice President, Corporate and Administrative Affairs and CFO
Lexicon Pharmaceuticals, Inc. (Spring, TX)

John Wehrli

Partner
Wilson Sonsini Goodrich & Rosati (San Diego, CA)

Janet Xiao

Partner
Morrison & Foerster LLP (Palo Alto, CA)

Jen Sieczkiewicz Zarutskie

VP, Chief Intellectual Property Counsel
Wave Life Sciences (Cambridge, MA)